Edges in Network
Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | GPR109B |
Upstream (Parents) |
---|
(<<) ARHGAP25 → GPR109B |
(<<) BCL2A1 → GPR109B |
(<<) CLEC2B → GPR109B |
(<<) CORO1A → GPR109B |
(<<) LCP1 → GPR109B |
(<<) MPP1 → GPR109B |
(<<) PIM1 → GPR109B |
(<<) PTPRE → GPR109B |
(<<) RHOG → GPR109B |
(<<) SLC25A37 → GPR109B |
(<<) SOD2 → GPR109B |
Downstream (Children) |
---|
GPR109B → ADAM8 (>>) |
GPR109B → ALPPL2 (>>) |
GPR109B → BCL6 (>>) |
GPR109B → BMPR2 (>>) |
GPR109B → CASP2 (>>) |
GPR109B → CASP5 (>>) |
GPR109B → CREB5 (>>) |
GPR109B → CSNK1E (>>) |
GPR109B → CSTA (>>) |
GPR109B → CXCL1 (>>) |
GPR109B → CYP4F2 (>>) |
GPR109B → DUSP1 (>>) |
GPR109B → EFHD2 (>>) |
GPR109B → ERBB2 (>>) |
GPR109B → FOXB1 (>>) |
GPR109B → FZD9 (>>) |
GPR109B → G0S2 (>>) |
GPR109B → GPX1 (>>) |
GPR109B → GYPC (>>) |
GPR109B → IL1B (>>) |
GPR109B → IL1F5 (>>) |
GPR109B → IL1R2 (>>) |
GPR109B → INE1 (>>) |
GPR109B → KCNJ2 (>>) |
GPR109B → KCNJ5 (>>) |
GPR109B → KLK3 (>>) |
GPR109B → KRT1 (>>) |
GPR109B → LGALS3 (>>) |
GPR109B → LIMK2 (>>) |
GPR109B → MAP2K3 (>>) |
GPR109B → MAP2K4 (>>) |
GPR109B → MAP3K3 (>>) |
GPR109B → MAPK11 (>>) |
GPR109B → MAPK12 (>>) |
GPR109B → MAPK7 (>>) |
GPR109B → MAPK8 (>>) |
GPR109B → MEGF6 (>>) |
GPR109B → MEX3D (>>) |
GPR109B → MMP25 (>>) |
GPR109B → MT3 (>>) |
GPR109B → NAB2 (>>) |
GPR109B → ORM1 (>>) |
GPR109B → PI3 (>>) |
GPR109B → PIP4K2A (>>) |
GPR109B → PKIG (>>) |
GPR109B → PLAUR (>>) |
GPR109B → PLEK2 (>>) |
GPR109B → PPP1R3D (>>) |
GPR109B → PTGS1 (>>) |
GPR109B → PTGS2 (>>) |
GPR109B → PYGL (>>) |
GPR109B → RAF1 (>>) |
GPR109B → RPL23A (>>) |
GPR109B → S100P (>>) |
GPR109B → SEMA3A (>>) |
GPR109B → SEPW1 (>>) |
GPR109B → SH3TC1 (>>) |
GPR109B → THRA (>>) |
GPR109B → TUBB2C (>>) |
GPR109B → TXNIP (>>) |
GPR109B → UBE2D3 (>>) |